Last edition
News about Drug Discovery & Development
Novartis has entered into a licensing agreement with Monte Rosa Therapeutics valued at up to 5.7 billion USD. The deal centres on developing medicines for immune-mediated diseases, where the immune system mistakenly attacks healthy tissue.
Drug Discovery & Development | 15/09/2025 | By Darshana | 249
Fermenta Biotech Secures Indian Patent for Plant-Based Vitamin D3 Invention
Fermenta Biotech has been granted a patent by the Indian Patent Office for its proprietary process to produce plant-based Vitamin D3.
Drug Discovery & Development | 12/09/2025 | By Dineshwori | 282
Merck, known as MSD outside the United States and Canada, has reported positive results from its Phase 3 STRIDE-13 trial evaluating Capvaxive, its 21-valent pneumococcal conjugate vaccine.
Drug Discovery & Development | 12/09/2025 | By Darshana | 159
Merck Shuts Down London Drug Discovery Centre, Moves R&D Focus to US
Merck has announced that it will discontinue its drug discovery operations in London, citing an increasingly challenging business environment in the UK. The company has abandoned plans to occupy the Belgrove House site at King’s Cross—which had been scheduled to open in 2027—and will relocate research activities primarily to existing sites in the USA.
Drug Discovery & Development | 12/09/2025 | By Darshana | 171
Alchemab Launches First-in-Human Trial of ATLX-1282, Secures 32 Million USD Financing Boost
Alchemab Therapeutics, a biopharmaceutical company that develops naturally occurring therapeutic antibodies from resilient individuals, has announced the initiation of its first-in-human phase 1 study of ATLX-1282.
Drug Discovery & Development | 10/09/2025 | By Darshana | 257
FDA tightens import controls on obesity drug ingredients amid safety concerns
The Food and Drug Administration (FDA) in the USA has intensified its scrutiny of imports containing GLP-1 drug ingredients, widely used in treatments for weight loss and diabetes, following increasing concerns over safety and quality.
Drug Discovery & Development | 06/09/2025 | By Darshana | 317
Roche Deploys Contivue Manufacturing Platform with CE Mark for nAMD Continuous Drug Delivery
Roche has received CE marking in the European Union for Contivue, its innovative Port Delivery Platform for administering Susvimo in the treatment of neovascular (wet) age-related macular degeneration (nAMD).
Drug Discovery & Development | 04/09/2025 | By Darshana | 191
Nanyang Biologics, NVIDIA, HPE and Equinix Collaborate to Build AI Drug Discovery Platform
Fischer Medical Ventures’ associate company, Nanyang Biologics (NYB), has entered into a strategic collaboration with global technology leaders NVIDIA, Hewlett Packard Enterprise (HPE), and Equinix to build VECURA – an AI-powered drug discovery platform.
Drug Discovery & Development | 03/09/2025 | By Dineshwori | 220
Piramal Pharma Solutions leveraged its CDMO expertise to help George Medicines develop WIDAPLIK, the first and only FDA-approved triple combination therapy for hypertension, combining telmisartan, amlodipine, and indapamide to effectively lower blood pressure.
Drug Discovery & Development | 01/09/2025 | By Mrinmoy Dey | 131
US FDA Accepts Gadoquatrane for Review: Bayer
Bayer has submitted New Drug Application (NDA) for low dose contrast agent gadoquatrane to seek approval for contrast-enhanced Magnetic Resonance Imaging (MRI) of the Central Nervous System (CNS) and other body regions for adults and paediatric patients including neonates.
Drug Discovery & Development | 27/08/2025 | By Dineshwori | 100
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy